Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H PENNINGTON

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
International Journal of Antimicrobial Agents|January 30, 2022
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2Laura N Jeffreys, Shaun H Pennington, Jack Duggan, et al.
Wellcome Open Research|September 2, 2024
A feasibility study of controlled human infection with intradermal Bacillus Calmette-Guérin (BCG) injection: Pilot BCG controlled human infection modelEmma Carter, Ben Morton, Dima ElSafadi, et al.
Viruses|January 8, 2025
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden HamstersMegan Neary, Eduardo Gallardo-Toledo, Joanne Sharp, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
Vaccine|February 1, 2026
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studiesKaterina S Cheliotis, Patricia Gonzalez-Dias, Esther L German, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2023
Lack of antiviral activity of probenecid in vitro and in Syrian golden hamstersHelen J Box, Joanne Sharp, Shaun H Pennington, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
International Journal of Antimicrobial Agents|January 30, 2022
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2Laura N Jeffreys, Shaun H Pennington, Jack Duggan, et al.
Wellcome Open Research|September 2, 2024
A feasibility study of controlled human infection with intradermal Bacillus Calmette-Guérin (BCG) injection: Pilot BCG controlled human infection modelEmma Carter, Ben Morton, Dima ElSafadi, et al.
Viruses|January 8, 2025
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden HamstersMegan Neary, Eduardo Gallardo-Toledo, Joanne Sharp, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith Kr Rajoli, Henry Pertinez, Usman Arshad, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
Vaccine|February 1, 2026
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studiesKaterina S Cheliotis, Patricia Gonzalez-Dias, Esther L German, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2023
Lack of antiviral activity of probenecid in vitro and in Syrian golden hamstersHelen J Box, Joanne Sharp, Shaun H Pennington, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Pageof 14